Postherpetic Neuralgia
Conditions
Interventions
Control Group:Oral gabapentin capsule + thoracic paravertebral nerve block
Experimental Group:Oral gabapentin capsules + thoracic paravertebral nerve block + intradermal acupuncture (press needles)
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) In line with the "Chinese Expert Consensus on the Diagnosis and Treatment of postherpetic neuralgia" (2016 edition) PHN diagnostic criteria; (2) Age 18-75 years old; (3) PHN was diagnosed 1-3 months after the onset of herpes zoster; (4) The pain site is located in the chest and abdomen; (5) Voluntarily participate in the test and sign the informed consent; (6) VAS score =4 points;
Exclusion criteria
Exclusion criteria: (1) PHN in other parts; (2) serious systemic diseases; (3) Diabetes with poor blood sugar control; (4) Local or systemic infection of puncture; (5) Abnormal coagulation function; (6) Allergic constitution; (7) Patients who had used drugs that have therapeutic effects on PHN or had used glucocorticoids and immunosuppressants in the week before enrollment; (8) Other circumstances in which nerve block puncture is not appropriate. (9) Pregnant and lactating patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical Rating Scale(NRS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Vital Signs;Quality of Life Score; | — |
Countries
China
Contacts
Public ContactZheng junyi
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed